1. Jaing TH. Is the Benefit–Risk Ratio for Patients with Transfusion-Dependent Thalassemia Treated by Unrelated Cord Blood Transplantation Favorable?. International journal of molecular sciences. 2017 Nov;18(11):2472.
2. Van Besien, K.; Liu, H.; Jain, N.; Stock, W.; Artz, A. Umbilical cord blood transplantation supported by third-party donor cells: Rationale, results, and applications. Biol. Blood Marrow Transplant. 2013, 19, 682–691.
3. E. Gluckman, V. Rocha, W. Arcese, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol, 32 (2004), pp. 397-407
Rocha, F. Locatelli. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant, 41 (2008), pp. 207-214
Niehues, V. Rocha, A.H. Filipovich, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children—a Eurocord analysis. Br J Haematol, 114 (2001), pp. 42-48
Brunstein CG, Gutman JA, Weisdorf DJ et al. Allogeneic hematopoetic cell transplantation for hematologic malignancy: Relative risks and benefits of double umbilical cord blood. Blood 2010;116:4693–4699.
4. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993; 329: 840–844.
5. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18:295–304.
Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69:204–217.
6. Mohamed SY. Thalassemia Major: Transplantation or transfusion and chelation. Hematology/Oncology and Stem Cell Therapy. 2017 Dec 1;10(4):290-8.
7. Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Nigro LL, Ayas M, Purtill D. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biology of Blood and Marrow Transplantation. 2011 Sep 1;17(9):1375-82.
8. IssagrisilSVisuthisakchaiSSuvatteVet alBrief report: transplantation of cord-blood stem cells into a patient with severe thalassemia.N Engl J Med.3321995367369
Google ScholarCrossref PubMed
LauYLMaESHaSYet alSibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin and review of the literature.J Pediatr Hematol Oncol.201998477481
9. WagnerJEKernanNASteinbuchMBroxmeyerHEGluckmanEAllogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease.Lancet.461995214219
GluckmanERochaVBoyer-ChammardAet alOutcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.N Engl J Med.3371997373381
LocatelliFRochaVChastangCet alFactors associated with outcome after cord blood transplantation in children with acute leukemia.Blood.93199936623671
RochaVWagner-JESobocinskiKAet alGraft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.N Engl J Med.342200018461854
10. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, Li X, Nagler A, Giorgiani G, Haut PR. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003 Mar 15;101(6):2137-43.
11. P. Rubinstein, C. Carrier, A. Scaradavou, et al.
Outcomes among 562 recipients of placental-blood transplants from unrelated donors
N Engl J Med, 339 (1998), pp. 1565-1577
Gluckman, V. Rocha, A. Boyer-Chammard, et al.
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group
N Engl J Med, 337 (1997), pp. 373-381
Gluckman, V. Rocha, I. Ionescu, et al.
Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant, 13 (2007), pp. 1073-1082
12. Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Nigro LL, Ayas M, Purtill D. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biology of Blood and Marrow Transplantation. 2011 Sep 1;17(9):1375-82.
13. Champlin RE, Horowitz MM, van Bekkum DW, et al. Graftfailure following bone marrow transplantation for severe aplasticanemia: risk factors and treatment results.Blood. 1989;73:606-613.
14. GazievDPolchiPGalimbertiMet alGraft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.Transplantation.631997854860
15. AtkinsonKChronic graft-versus-host disease.Bone Marrow Transplant.519906982
16. Bradley MB, Cairo MS. Cord blood immunology and stem cell transplantation. Human Immunology. 2005;66(5):431-46.
17. WagnerJEKernanNASteinbuchMBroxmeyerHEGluckmanEAllogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease.Lancet.461995214219
GluckmanERochaVBoyer-ChammardAet alOutcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.N Engl J Med.3371997373381
RochaVWagner-JESobocinskiKAet alGraft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.N Engl J Med.342200018461854
18. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, Li X, Nagler A, Giorgiani G, Haut PR. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003 Mar 15;101(6):2137-43.
19. G. Lucarelli, R.A. Clift, M. Galimberti, P. Polchi, E. Angelucci, D. Baronciani, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients, Blood, 87 (1996), pp. 2082-2088
Sabloff, M. Chandy, Z. Wang, B.R. Logan, A. Ghavamzadeh, C.K. Li, et al. HLA-matched sibling bone marrow transplantation for beta-thalassemia major, Blood, 117 (2011), pp. 1745-1750
Mathews, B. George, A. Viswabandya, A. Abraham, R. Ahmed, A. Ganapule, et al. Improved clinical outcomes of high risk beta thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts, PLoS ONE, 8 (2013)
19. N. Kabbara. A multicentric comparative analysis of outcomes of HLA identical related cord blood and bone marrow transplantation in patients with beta-thalassemia or sickle cell disease. Bone Marrow Transplant, Abs184, 41 (2008), pp. 29-30
20. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, Fukuno K, Uchiyama M, Takasugi K, Iseki T, Tojo A. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood. 2007 Feb 1;109(3):1322-30.